Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Preliminary efficacy and safety data for an HIV therapeutic vaccine

Feb. 3, 1997

Ganciclovir prodrug shows potential for treatment of CMV retinitis

Feb. 3, 1997

British scientists describe novel therapeutic approach to HIV

Feb. 3, 1997

PMPA prodrug selected as clinical candidate

Feb. 3, 1997

Gilead selects GS-930 prodrug for further evaluation

Feb. 3, 1997

Aronex describes anti-HCMV compound

Feb. 3, 1997

Genotypic analysis of patients treated with adefovir dipivoxil

Jan. 31, 1997

Cel-Sci presents results with heteroconjugate technology for HIV vaccine development

Jan. 31, 1997

NCI discloses anti-HIV agent with novel mechanism of action

Jan. 31, 1997

Abbott develops protease inhibitor for combination therapy

Jan. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...